These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
549 related articles for article (PubMed ID: 30592634)
1. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway. Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634 [TBL] [Abstract][Full Text] [Related]
2. MIF-Induced Stromal PKCβ/IL8 Is Essential in Human Acute Myeloid Leukemia. Abdul-Aziz AM; Shafat MS; Mehta TK; Di Palma F; Lawes MJ; Rushworth SA; Bowles KM Cancer Res; 2017 Jan; 77(2):303-311. PubMed ID: 27872094 [TBL] [Abstract][Full Text] [Related]
3. Bone marrow stromal cells protect acute myeloid leukemia cells from anti-CD44 therapy partly through regulating PI3K/Akt-p27(Kip1) axis. Chen P; Huang H; Wu J; Lu R; Wu Y; Jiang X; Yuan Q; Chen Y Mol Carcinog; 2015 Dec; 54(12):1678-85. PubMed ID: 25408361 [TBL] [Abstract][Full Text] [Related]
4. Peptide hormone ELABELA promotes rat bone marrow-derived mesenchymal stem cell proliferation and migration by manipulating the cell cycle through the PI3K/AKT pathway under the hypoxia and ischemia microenvironment. Chen X; Zhou C; Xu D; Liu X; Li S; Hou J; Zhang K; Zeng C; Zheng G; Wu H; Wu H; Wang W; Fu J; Wang T Stem Cell Res Ther; 2022 Jan; 13(1):32. PubMed ID: 35090551 [TBL] [Abstract][Full Text] [Related]
5. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling. Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985 [TBL] [Abstract][Full Text] [Related]
6. The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells. Brenner AK; Andersson Tvedt TH; Bruserud Ø Molecules; 2016 Nov; 21(11):. PubMed ID: 27845732 [TBL] [Abstract][Full Text] [Related]
7. Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody. Chapuis N; Tamburini J; Cornillet-Lefebvre P; Gillot L; Bardet V; Willems L; Park S; Green AS; Ifrah N; Dreyfus F; Mayeux P; Lacombe C; Bouscary D Haematologica; 2010 Mar; 95(3):415-23. PubMed ID: 20007139 [TBL] [Abstract][Full Text] [Related]
8. CD4+ T cells from patients with acute myeloid leukemia inhibit the proliferation of bone marrow-derived mesenchymal stem cells by secretion of miR-10a. Yu Z; Li D; Ju XL J Cancer Res Clin Oncol; 2016 Apr; 142(4):733-40. PubMed ID: 26590574 [TBL] [Abstract][Full Text] [Related]
9. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway. Shen T; Yang Z; Cheng X; Xiao Y; Yu K; Cai X; Xia C; Li Y Oncol Rep; 2017 Apr; 37(4):2095-2100. PubMed ID: 28259918 [TBL] [Abstract][Full Text] [Related]
10. Prazosin inhibits the proliferation and survival of acute myeloid leukaemia cells through down-regulating TNS1. Sun X; Yang S; Song W Biomed Pharmacother; 2020 Apr; 124():109731. PubMed ID: 31954876 [TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor miR-139-5p targets Tspan3 and regulates the progression of acute myeloid leukemia through the PI3K/Akt pathway. Zhang R; Tang P; Wang F; Xing Y; Jiang Z; Chen S; Meng X; Liu L; Cao W; Zhao H; Ma P; Chen Y; An C; Sun L J Cell Biochem; 2019 Mar; 120(3):4423-4432. PubMed ID: 30367526 [TBL] [Abstract][Full Text] [Related]
12. A novel iheyamine A derivative L42 suppresses acute myeloid leukemia via dual regulation of the PI3K/AKT/FOXO3a axis and TNF signaling pathway. Dinghuan W; Yi K; Jianzhi T; Wenfei W; Chunlin W; Anling H; Zhixu H; Ben-David Y; Sheng L; Xiaoyan Y; Xiao X Biomed Pharmacother; 2024 Aug; 177():117071. PubMed ID: 38981243 [TBL] [Abstract][Full Text] [Related]
13. CXCL8 promotes the invasion of human osteosarcoma cells by regulation of PI3K/Akt signaling pathway. Jiang H; Wang X; Miao W; Wang B; Qiu Y APMIS; 2017 Sep; 125(9):773-780. PubMed ID: 28736978 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway. Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680 [TBL] [Abstract][Full Text] [Related]
15. Zhou JD; Li XX; Zhang TJ; Xu ZJ; Zhang ZH; Gu Y; Wen XM; Zhang W; Ji RB; Deng ZQ; Lin J; Qian J Aging (Albany NY); 2019 May; 11(10):3376-3391. PubMed ID: 31147526 [No Abstract] [Full Text] [Related]
16. Hydrogen sulfide augments the proliferation and survival of human induced pluripotent stem cell-derived mesenchymal stromal cells through inhibition of BKCa. Zhao Y; Wei H; Kong G; Shim W; Zhang G Cytotherapy; 2013 Nov; 15(11):1395-405. PubMed ID: 23992829 [TBL] [Abstract][Full Text] [Related]
17. IL-8 Enhances Therapeutic Effects of BMSCs on Bone Regeneration via CXCR2-Mediated PI3k/Akt Signaling Pathway. Yang A; Lu Y; Xing J; Li Z; Yin X; Dou C; Dong S; Luo F; Xie Z; Hou T; Xu J Cell Physiol Biochem; 2018; 48(1):361-370. PubMed ID: 30016780 [TBL] [Abstract][Full Text] [Related]
18. Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment. Zeng Z; Shi YX; Tsao T; Qiu Y; Kornblau SM; Baggerly KA; Liu W; Jessen K; Liu Y; Kantarjian H; Rommel C; Fruman DA; Andreeff M; Konopleva M Blood; 2012 Sep; 120(13):2679-89. PubMed ID: 22826565 [TBL] [Abstract][Full Text] [Related]
19. Human amniotic mesenchymal stem cells and their paracrine factors promote wound healing by inhibiting heat stress-induced skin cell apoptosis and enhancing their proliferation through activating PI3K/AKT signaling pathway. Li JY; Ren KK; Zhang WJ; Xiao L; Wu HY; Liu QY; Ding T; Zhang XC; Nie WJ; Ke Y; Deng KY; Liu QW; Xin HB Stem Cell Res Ther; 2019 Aug; 10(1):247. PubMed ID: 31399039 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype. Liu Y; Chen Y; Liu Y; Li M; Zhang Y; Shi L; Yang L; Li T; Li Y; Jiang Z; Liu Y; Wang C; Wang S J Transl Med; 2022 Dec; 20(1):612. PubMed ID: 36550462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]